International Clinical Trial: A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07827599) titled 'A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants' on Sept. 15.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Hoffmann-La Roche

Condition: Influenza, Human Respiratory Tract Infections Post-exposure Prophylaxis

Intervention: Drug: Baloxavir marboxil

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: September 2...